LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER …leapingforward.hospitaldaluz.pt/media/277253/programas_total_sem... · in metastatic rectal cancer ... Update on RAPIDO trial - preoperative

Opening & registration08:00 AM

Welcome and IntroductionTânia Rodrigues (PT) | Pedro Amado (PT) | José António Pereira (PT)

08:15 AM

Round Table 1 | New problems in management of liver synchronous metastases in metastatic rectal cancer

Neoadjuvant therapy: how are preoperative radio and chemotherapy applied in a simultaneous approach?Teresa Macarulla (SP) Surgical options: is surgical timing important?Joan Figueras (SP)

Complete response in rectal cancer with synchronous liver metastases Guilherme São Julião (BR)

Managing the “vanishing” synchronous liver lesions René Adam (FR)

Discussion

PRELIMINARY PROGRAMME9 MAY 2017 > AUDITORIUM 1

LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER SESSION

Opening Ceremony12:30 PM

Coffee Break11:00 PM

08:30 AM

Diagnosis and treatment of cancer patients: hail to a combination of precision and narrative medicine Manuel Sobrinho Simões (PT)

02:30 PM

Lunch01:30 PM

Round Table 2 | Intrahepatic Cholangiocarcinoma

Diagnostic imagingRichard C. Semelka (US)

Neoadjuvant treatmentTeresa Macarulla (SP)

Surgical management and the role of lymphadenectomySafi Dokmak (FR)

New procedures for the Treatment of Liver Metastases of GI Tumors - ChemosaturationFrank K. Wacker (DE)

Discussion

Round Table 3 | Safe liver surgery

PVE /ALLPS: Volume = Function?functional liver remnant assessmentThomas Aloia (US)

Parenchymal sparing surgeryGuido Torzilli (IT)

04:30 PM


Management of post-operative liver failureSafi Dokmak (FR)

Discussion

Closing remarksCatarina Fidalgo (PT)

06:00 PM

Director: José António Pereira | Tânia Rodrigues | Pedro Amado

Speakers: Catarina Fidalgo | Carlos Ferreira | Frank K. Wacker | Guido Torzilli | Guilherme São Julião | Joan FiguerasJosé Costa Maia | Manuel Sobrinho Simões | René Adam | Richard C. Semelka | Rui Maio | Safi Dokmak | Teresa Macarulla Thomas Aloia

Opening & registration

Welcome and IntroductionFernando Martelo (PT)

Molecular targets of lung cancer in the near futureRafael Rosell (SP)

Round Table 1 | Future of staging of lung-cancer patients

MRI in lung cancer stagingBruno Hochhegger (BR)

PET/CT or PET/MRI? Gustav von Schulthess (SW)

Video-assisted mediastinal lymphadenectomy Martin Hürtgen (DE)

Image-guided localization platform for EBUS and ultra-minimally invasive lung cancer surgeryKazuhiro Yasufuku (CA)

Coffee Break

Lunch

Opening Ceremony (Auditorium 1)

PRELIMINARY PROGRAMME 9 MAY 2017 > AUDITORIUM 2

LEAPING FORWARD ONCOLOGY LUNG CANCER SESSION

08:00 AM

08:45 AM

09:00 AM

09:45 AM

11:45 PM

11:15 PM

01:30 PM

12:30 PM

02:30 PM

03:45 PM

04:15 PM

05:10 PM

06:00 PM

Directors: Fernando Martelo | Marcos Pantarotto | Margarida Felizardo

Speakers: Bernard Park | Bruno Hochhegger | Christian Rolfo | Gustav von Schulthess | Hans Henrik Madsen | Kazuhiro Yasufuku Martin Hürtgen | Puneeth Iyengar | Rafael Rosell | Rosário Garcia Campelo

Round Table 2 | Locoregional treatment of lung cancer – future directions & controversies

Minimally invasive surgery – a place for robotic surgery? Bernard Park (US)

SBRT in cT1 and cT2: current consensus and controversiesPuneeth Iyengar (US)

RFA and MWA in early-stage-lung and metastatic disease – from promises to answersHans Henrik Madsen (DK)

Coffee Break

Round Table 3 | Metastatic non-small cell lung cancer

Target-directed treatment – our direction now Rosario Garcia Campelo (SP)

Radical treatment of the oligometastatic disease at diagnosis Puneeth Iyengar (US)

Current & future challenges in lung cancer trialsChristian Rolfo (BE)

Closing remarksMargarida Felizardo (PT) | Marcos Pantarotto (PT)


Welcome and IntroductionMaria Manso (PT) | Luís Féria (PT) | Rui Maio (PT)

08:15 AM

ERAS – Overview (history, keys concepts, goals)Luís Féria (PT)

08:30 AM

Round Table 1 | ERAS implementation

The implementation programSusana Barreira (PT)

The Portuguese experienceMaria Manso (PT)

The interactive audit systemCarlos Pereira (PT) Discussion

08:50 AM


LEAPING FORWARD ONCOLOGY ERAS SESSION

Coffee Break10:30 AM

A different implementation experienceThomas Aloia (US)

10:00 AM

Directors: Maria Manso | Luís Féria | Rui Maio

Speakers: Andreia Ferreira | Carlos Pereira | Francisco Mota | Joana Oliveira | Susana Barreira | Thomas Aloia

Round Table 2 | ERAS – Different perspectives for the same goal

The Surgeon Luís Féria (PT)

The AnesthesiologistJoana Oliveira (PT)

The NurseSusana Barreira (PT)

The Nutritionist Andreia Ferreira (PT)

Discussion

11:05 AM

Closing remarksMaria Manso (PT)

12:15 PM

Opening Ceremony (Auditorium 1)12:30 PM

Through the eyes of managementFrancisco Mota (PT)

10:45 AM

Cancer and the medical simulation center – The MD Anderson´s experienceGregory Botz (US)

05:45 PM

Welcome and IntroductionFrancisca Leite (PT) | Rui Maio (PT)

02:30 PM

Innovation Biomedical educationMadalena Patrício (PT)

Educational technology and innovations to training and patient care using simulationFernando Bello (UK)

Pro-con debate: the impact of simulation on translational patient outcomes Pro: William Mcgaghie (US) TBC Con: Nuno Freitas (PT)

F1 tech in the outside world – How Williams’s pit perfection can improve healthcare teamsGemma Fisher (UK) TBC


LEAPING FORWARD ONCOLOGY SIMULATION IN ONCOLOGY SESSION

Coffee Break

05:15 PM

02:45 PM

03:15 PM

03:45 PM

04:15 PM

Opening & registration02:15 PM

Post simulation era in medicineRichard Satava (US)

04:45 PM

Closing remarksTBD

06:15 PM

Director: Francisca Leite | Rui Maio

Speakers: Fernando Bello | Gemma Fisher | Gregory Botz | Madalena Patrício | Nuno Freitas | Richard Satava | William Mcgaghie


11:15 AM

Welcome and IntroductionTânia Rodrigues (PT) | Pedro Marques (PT) | Rui Maio (PT)

08:45 AM

Round Table 1 | Understanding pancreatic cancer

Factors that control progression from normal pancreatic epithelia to cancer Howard Crawford (US)

Molecular medicine in pancreatic cancer decision-making Laura Wood (US)

Role of the stromal cells in pancreatic cancer: promoter or protectorAndrew Rhim (US)

Clinical management of pancreatic cystic neoplasms: treatment or watchful waiting? Pedro Pinto Marques (PT)

09:00 AM

Personalized treatment in pancreatic cancerManuel Hidalgo (US)

10:30 AM


LEAPING FORWARD ONCOLOGY PANCREATIC CANCER SESSION

Coffee break

Lunch01:30 PM

Round Table 2 | Resectable pancreatic cancer: improving outcome

Enlarging the scope of Neoadjuvant Treatment:

Pro: Beyond borderline resectable? Thomas Seufferlein (DE)

Con: Selecting chemoresistant clones? Daniela Dias Santos (US) When to perform a pancreaticoduodenectomy in the absence of a positive histology Jacob Izbicki (DE)

Pancreatic carcinoma: implications of lymph nodes invasionNappo Gennaro (IT)

The future of adjuvant therapyJohn Neoptolemos (UK)

Round Table 3 | Challenges in locally advanced pancreatic cancer

Surgery for advanced pancreatic cancerMarkus W. Büchler (DE)

When, why and how is radiotherapy useful in pancreatic cancer?Florence Huguet (FR)

How to improve survival with current treatments?Margaret Tempero (US)

02:30 PM

04:30 PM Coffee break

11:45 AM

Directors: Rui Maio | Tânia Rodrigues | Pedro Marques

Speakers: Ana Faria | Andrew Rhim | Florence Huguet | Francisco Castro e Sousa | Howard Crawford | Jacob IzbickiJean Robert Delpero | John P. Neoptolemos | Laura Wood | Margaret Tempero | Markus W. Büchler | Manuel Hidalgo | Nappo Gennaro Thomas Seufferlein

State of the art in pancreatic surgery Jean Robert Delpero (FR)

05:00 PM

06:00 PM Closing remarksTânia Rodrigues (PT)


LEAPING FORWARD ONCOLOGY BREAST CANCER SESSION


Welcome and IntroductionJosé Luís Passos Coelho (PT)

08:45 AM

Update in imaging breast cancer: MRI and PET / MRIJohannes Grueneisen (DE)

09:00 AM

Coffee Break

Round Table 1 | Hereditary breast cancer

BRCA1/2 testing or gene-panel sequencing? Gareth Evans (UK)

How to deal with variants of uncertain significance and non-BRCA mutations Diana Eccles (UK)

Management of healthy BRCA mutation carriersRita Schmutzler (DE)

Implications for treatment of BRCA-mut breast cancer Judith Balmaña (SP)

09:30 AM

11:15 AM

Round Table 2 | Issues in the locoregional treatment of early breast cancer

Towards minimal surgery in the treatment of early breast cancerMonica Morrow (US)

Tailoring RT: integrating with breast reconstruction and axillary treatment Beryl McCormick (US)

Breast reconstruction – when and for whomJaume Masia (SP)

11:45 AM

Round Table 3 | Issues in the systemic treatment of breast cancer

ER and GFR signalling Kent Osborne (US)

Residual disease after preop chemotherapy – what should we do?Nadia Harbeck (DE)

Targetting intracellular pathways Mafalda Oliveira (SP)

02:45 PM


Lunch01:00 PM

Biology of breast cancer in 2017 Carlos Caldas (UK)

02:00 PM

Directors: José Luís Passos Coelho

Speakers: Beryl McCormick | Carlos Caldas | Diana Eccles | Gareth Evans | Jaume Masia | Johannes Grueneisen | Judith BalmañaKent Osborne | Luís Costa | Mafalda Oliveira | Monica Morrow | Nadia Harbeck | Paulina Lopes | Rita Schmutzler | Robert E. Coleman

Round Table 4 | Beyond the cancer cell

Bone Health in curable breast cancerLuís Costa (PT)

Bone targeting agents as adjuvant treatment of breast cancerRobert E. Coleman (UK)

04:45 PM

Closing remarksPaulina Lopes (PT) | José Luís Passos Coelho (PT)

05:45 PM


Welcome and IntroductionGraça André (PT) | Jorge Freitas (PT) | Dora Franco (PT) | Costa Dias (PT)

09:00 AM


LEAPING FORWARD ONCOLOGY ONCOLOGY NURSING SESSION

09:30 AM Round table 1

Oncology Nurse NavigatorMary Ann B. Case (US)

Nurse help line for cancer patientsNaomi Fitzgibbon (IE)

Role of the oncology nurse in the follow-up of cancer survivors and their families TBD

11:00 AM Coffee Break

11:30 AM Round table 2

Non-pharmacological therapies in the follow-up of cancer patientsGraça Folhas (PT)

Nursing consultation on the promotion of quality of life in patients with oncology woundHelena Vicente (PT)

Psychosocial intervention – the role of the oncology nurseCherith Semple (IE)

Director: Graça André | Marisa Falé

Faculty: Ana Santos Pereira | Cherith Semple | Costa Dias | Graça André | Graça Folhas | Helena Vicente | Margarida FaustinoMary Ann B. Case | Naomi Fitzgibbon | Sónia Caixeirinho

Closing remarksGraça André (PT)

01:00 PM


LEAPING FORWARD ONCOLOGY BODY COMPOSITION AND NUTRITION

04:00 PM

04:30 PM

05:30 PM

Round Table | The relevance of body composition in cancer patients

Imaging methods to assess body composition: a new era of nutritional assessment and intervention Carla Prado (CA)

Body composition in GI cancer patients: a prospective studySónia Velho (PT)

Body composition as a determinant of pharmacokinetics and toxicity Carla Prado (CA)

Coffee Break

Hands-on Session | Body composition analysis with computerized axial tomography imagesSónia Velho (PT) | Lisa Agostinho (PT) | Rita Cruz (PT)

Sarcopenic obesity and surgical outcome in cancer patients Carla Prado (CA)

02:30 PM

02:00 PM Welcome and IntroductionMarília Cravo (PT) | Sónia Velho (PT) | Rui Maio (PT)


Directors: Marília Cravo | Sónia Velho | Rui Maio

Faculty: Carla Prado | Lisa Agostinho | Rita Cruz

06:30 PM Closing remarksMarília Cravo (PT)


Discussion

Welcome and IntroductionSusana Ourô (PT) | Paulo Roquete (PT) | Catarina Fidalgo (PT)

Round Table 1 | General

08:15 AM

Molecular markers in colorectal cancer: miRNAs and its clinical implicationsCecília Rodrigues (PT)

Cancer family syndromes: polyposis registrySue Clark (UK)

New prognostic factors in colorectal oncological surgeryPhilip Quircke (UK)

08:30 AM

Round Table 2 | Colon cancer

The importance of the complete mesocolic excision (CME)Werner Hohenberger (DE)

Predicting middle colic vasculature and CME techniqueRobin Kennedy (UK)

Function after intersphincteric resection: how far can we go?Quentin Denost (FR)

10:00 AM


LEAPING FORWARD ONCOLOGY COLORECTAL CANCER SESSION

Discussion

Lunch01:30 PM

Round Table 3 | Rectal cancer I: staging, neoadjuvant therapy and decision making

MRI guided decisions and MRI/pathology quality control in rectal cancer Svetlana Balyasnikova (UK) Update on RAPIDO trial - preoperative induction therapyCornelis van de Velde (NL)

Predicting complete response: is there a role for non-operative management of rectal cancer?Karyn A. Goodman (US)

Local excision after chemo radiotherapy: danger or caution? Susana Ourô (PT)

Discussion

12:00 PM

Round Table 4 | Rectal cancer II: minimally invasive surgery

Transanal endoscopic surgery: indications for TEM, TAMIS, TEOSam Atallah (US)

TaTME: indications, surgical technique and pitfallsJoep Knol (BE)

TaTME: current evidence and functional resultsRoel Hompes (UK)

Robotic TME versus laparoscopic TMESeon Kim (KR)

02:30 PM


Discussion

Directors: Susana Ourô | Paulo Roquete | Catarina Fidalgo

Speakers: Cecília Rodrigues | Cornelis van de Velde | Haney Youssef | Ian Jenkins | Joep Knol | Karyn A. Goodman | Quentin DenostRobin Kennedy | Roel Hompes | Philip Quircke | Sam Atallah | Sue Clark | Seon Kim | Svetlana Balyasnikova | Werner Hohenberger

Round Table 5 | Colorectal cancer: how far can we go?

Indications for ELAPE?Philip Quircke (UK)

Surgical strategies in local recurrencyIan Jenkins (UK)

Cytoreductive surgery and HIPEC in colorectal cancerHaney Youssef (UK)

Discussion

04:30 AM


Closing remarksSusana Ourô (PT)

06:00 PM

08:15 AM

09:00 AM

09:15 AM

10:00 AM

11:30 AM

12:00 PM


Welcome and IntroductionMónica Nave (PT)

Ovarian cancer pathology: new emerging conceptsJaime Prat (SP)

Round table 1 | Ovarian cancer

Intraperitoneal chemotherapy: integration of clinical trial data in clinical practiceAntonio Gonzalez (SP)

DNA repair inhibitors: iPARP and beyondMansoor Raza Mirza (DK)

Surgery (and more surgery) in ovarian cancerLuis Chiva (SP)


LEAPING FORWARD ONCOLOGY GYNECOLOGICAL CANCER SESSION

Coffee Break

Immunotherapy in gynecologic cancerThais Baert (BE)

01:00 PM

02:00 PM

02:45 PM

04:45 PM

04:15 PM

Lunch

Update in imaging in gynecologic cancer: special focus on whole body MRI and PETJohannes Grueneisen (DE)

Round table 2 | Cervical cancer

Sentinel node biopsy and lymphadenectomy in cervical cancer: current statusDavid Cibula (CZ)

Neoadjuvant and adjuvant chemotherapy in cervical cancerGiovanni Aletti (IT)

Systemic therapy in metastatic cervical cancerAna Oaknin (SP)

Round table 3 | Endometrial cancer

Para-aortic lymph node dissection in endometrial cancer: the debate still evolvesMário Leitão (US)

Update in Radiation therapy in uterine cancerAlexandra Taylor (UK)

Systemic therapy in endometrial cancerBarbara Goff (US)

Coffee Break

Director: Mónica Nave

Speakers: Alexandra Taylor | Ana Oaknin | Antonio Gonzalez | Barbara Goff | David Cibula | Giovanni Aletti | Gustavo Mendinhos Jaime Prat | Johannes Grueneisen | Luis Chiva | Mansoor Raza Mirza | Mario Leitão | Thais Baert

Closing remarksMónica Nave (PT) | Gustavo Mendinhos (PT)

06:30 PM


Welcome and IntroductionIsabel Galriça Neto (PT)

08:45 AM

Improving the lived experience with cancer: better treatment for allEdna Gonçalves (PT)

ESMO E-Learning: integrated oncology and palliative careRita Canário (PT)

The changing conversation around prognostication David Hui (US)


LEAPING FORWARD ONCOLOGY PALLIATIVE CARE SESSION


09:00 AM

09:30 AM

10:00 AM

Case-mix, typologies and complexity in palliative care Bárbara Gomes (UK)

Compassion: the essence of palliative and end of life care Philip Larkin (IE)

11:30 AM

12:00 PM

Closing remarksIsabel Galriça Neto (PT)

12:30 PM

Director: Isabel Galriça Neto

Speakers: Bárbara Gomes | David Hui | Edna Gonçalves | Philip Larkin | Rita Canário

Welcome and IntroductionCristina Pestana (PT) | Kris Maes (PT)

02:00 PM

The creation of value with a patient-centered simulation strategyAntoine Tesnière (FR)

04:30 PM

05:00 PM

05:30 PM

Improving performance gaps to impact patient safetyFrancisco Maio Matos (PT)

Parallel Workshops | Surgical Simulations (Exhibition Hall)NeuroVR - Open cranial and endoscopic brain surgeryResearch team (CA) | Domingos Coiteiro (PT)

Strategies for healthcare surgical education GYN minimally invasive procedures Filipa Osório (PT)

Robotic surgery teaching program Kris Maes (BE)

Onco-anesthesia: simulation-based education, a strategy to improve patient outcomesCristina Pestana (PT)


LEAPING FORWARD ONCOLOGY SIMULATION IN SURGICAL ONCOLOGY SESSION

Coffee Break

04:00 PM

02:15 PM

03:00 PM

03:30 PM


The role of non-technical skills in surgical teams performance Carla Sá Couto (PT)

Microsoft Hololens – How virtual environment will transform healthcare

SECTRA Table – A tool for surgery planning

Minimally Invasive Surgery – Endoscopy, Laparoscopy and Robotics

Director: Cristina Pestana | Kris Maes

Speakers: Antoine Tesnière | Carla Sá Couto | Cristina Pestana | Domingos Coiteiro | Filipa Osório| Francisco Maio MatosKris Maes

Round Table 1 | NET - old myths, new age

Round Table 2 | NET - irrelevant findings?

Gastroduodenal NET- the meaning of “small, silent and benign”Francesco Panzuto (IT)

11:30 AM


LEAPING FORWARD ONCOLOGY NEUROENDOCRINE TUMORS SESSION


NET genetic profile - genetic syndrome or hereditary risk?TBD

09:00 AM

Histopathology NET G3 vs NEC G3Ana Catarino (PT)

Biomarkers for NETs - what else?Tim Meyer (UK)

Novel radioisotopesRichard Baum (DE)

Discussion


Welcome and IntroductionTeresa Timóteo (PT) | Rita Roque (PT) | Rosário Vieira (PT)

08:45 AM

Appendiceal NET - innocent or guilty? Ulrich Peter Knigge (DK)

Rectal NET - prognostic factors John Ramage (UK)

Discussion

Non-functioning pancreatic NETs - wait and see or intervene?Jorge Barriuso (UK)

Round Table 3 | Locoregional therapy for NET liver metastasis

Image-guided liver metastasis ablation: percutaneous therapiesBelarmino Gonçalves (PT)

Transarterial embolization: yttrium radioembolization (SIRT)Macarena Rodriguez-Fraile (SP)

From hepatic resection to hepatic transplantAndreas Pascher (DE)

Discussion

02:30 PM

Round Table 4 | Systemic therapy for NET metastasis

Targeted therapies vs chemotherapy - what's new?Jaume Capdevila (SP)

04:30 PM

Lunch01:30 PM


Pulmonary NET and GEP NET - a different approach? Kjell Öberg (SE)

Discussion

20 years of THERANOSTICS experience in neuroendocrine tumors - past, present and future of peptide receptor radionuclide therapy (PRRT)Richard Baum (DE)

Closing remarksRita Roque (PT)

06:00 PM

05:30 PM

Director: Teresa Timóteo | Rita Roque | Rosário Vieira

Speakers: Ana Catarino | Andreas Pascher | Belarmino Gonçalves | Francesco Panzuto | Jaume Capdevila John Ramage | Jorge Barriuso | Kjell Öberg | Macarena Rodriguez-Fraile | Richard Baum | Tim Meyer | Ulrich Peter Knigge


LEAPING FORWARD ONCOLOGY UROLOGICAL CANCER SESSION


Welcome and IntroductionKris Maes (PT) | Francisco Mascarenhas (PT)

08:15 AM

PROSTATE CANCER

Round Table 1 | Image-guided diagnosis and treatment in prostate cancer

For how much longer will we be using the Gleason score? New kids on the blockFernando Algaba Arrea (SP)

Impact of MRI MP and MRI-targeted biopsies in diagnosis of prostate cancer Geert Villeirs (BE)

Role of MRI in staging and management of advanced prostate cancerNina Tunariu (UK) Discussion

08:30 AM

Round Table 2 | Controversies in treatment of low and medium risk prostate cancer: focal therapy

HIFU focal therapyEric Potiron (FR)

Radiation focal therapyFerran Guedea (SP)

09:30 AM

Round Table 3 | How does the future treatment of low risk and intermediate risk PC looks like

For the radiation oncologistPatrick Kupelian (US)

For the surgeon Steven Joniau (BE)

Debate | High risk prostate cancer: the futureLuís Campos Pinheiro (PT)

Radiation therapy Patrick Kupelian (US)

Radical prostatectomyArnulf Stenzl (DE)

Discussion

10:45 AM

11:30 AM


Lunch 01:00 PM

12:15 PM TESTICULAR CANCER

Surgical issues in testicular cancer: a) Adjuvant RPLND for whom? b) Role of surgery for residual disease after chemotherapy Rafael Coelho (BR)

Round Table 4 | The management of recurrent prostate cancer after local treatment

Salvage prostatectomy/lymphadenectomy: when and how Steven Joniau (BE)

Salvage radiotherapy: when and how Ferran Guedea (SP)

Systemic therapy: when and how Robert Jones (UK)

02:00 PM

Round Table 5 | Future perspectives for treatment of advanced disease

Management of mCRPC: chemotherapy for hormone naïve metastatic patientsRobert Jones (UK)

The power of precision medicine: PSMA radioligand therapy (PRLT) of end-stage prostate cancer patients selected by PSMA PET/CTAviral Singh (DE) | Richard Baum (DE)

Coffee Break

03:00 PM

04:00 PM

BLADDER CANCER

Current and future treatment of NMIBC Oscar Rodriguez (SP)

Who profits from neo-adjuvant chemotherapy for MIBCFabio Schutz (BR)

Multimodal treatment of MIBC: external beam radiotherapy and robotic limited surgery plus brachytherapy for bladder cancerElzbieta van der Steen-Banasik (NL)

04:30 PM

Directors: Francisco Mascarenhas | Kris Maes

Faculty: Aviral Singh | Elzbieta van der Steen-Banasik | Eric Potiron | Fernando Algaba Arrea | Geert Villeirs | Nina Tunariu Oscar Rodriguez | Richard Baum | Robert Jones

Closing remarksTBD

06:00 PM

Discussion


Welcome and Introduction José Luís Passos Coelho (PT) | Marcos Pantarotto (PT)

09:00 AM


LEAPING FORWARD ONCOLOGY CANCER IMMUNOLOGY AND IMMUNOTHERAPY SESSION


What the Oncologist should know about the immune systemBruno Silva-Santos (PT)

09:15 AM

From bench to bedside – translating immunology into cancer immunotherapyBruno Silva-Santos (PT)

09:30 AM

Clinical challenges: evasion and resistance to cancer immunotherapyJuan Martin-Liberal (SP)

10:00 AM

Clinical challenges: response evaluation & toxicityMargarida Matias (FR)

10:30 AM

Personalized immunotherapyMarco Donia (DK)

11:30 AM

12:30 PM Discussion

Predictive and prognostic biomarkers for Immunotherapy TBD

02:00 PM

Immunotherapy for melanoma Marco Donia (DK)

02:30 PM

Lunch01:00 PM

Immunotherapy for lung cancer Johan Vansteenkiste (BE)

Immunotherapy for glioblastoma and CNS malignanciesPatrick Roth (CH)

03:30 PM

04:00 PM

Director: José Luís Passos Coelho | Marcos Pantarotto

Faculty: Bruno Silva-Santos | Ignacio Duran | Johan Vansteenkiste | Juan Martin-Liberal | Marco Donia Margarida MatiasPatrick Roth


04:30 PM

05:00 PM

Immunotherapy for genitourinary cancer Ignacio Duran (SP)

Round table – Q&A

Closing remarksTBD

05:30 PM

08:15 AM

08:45 AM

09:00 AM

11:30 AM

11:00 AM


Welcome and IntroductionCésar Resende (PT) | Tânia Rodrigues (PT) | Gonçalo Luz (PT) | Rui Maio (PT)

Round Table 1 | Carcinogenesis and management of early gastric lesions

Novelties of Helicobacter Pylori driven carcinogenesisFátima Carneiro (PT)

microRNAs in screening programs of high risk patients/ regions: how far are we? Carla Oliveira (PT)

Light-NBI to identify high-risk phenotypes for gastric cancer: do we still need biopsies? Mário Dinis Ribeiro (PT)

Endoscopic treatment of superficial gastric cancer: indications and pitfallsPedro Barreiro (PT)

Surgical treatment of gastric cancer: mini invasive surgery - standard of careRubens Sallum (BR)


LEAPING FORWARD ONCOLOGY ESOPHAGUS AND GASTRIC CANCER SESSION

Coffee Break

12:30 PM

03:30 PM

01:30 PM

03:00 PM

04:00 PM

Lunch

Coffee Break

Round Table 2 | Is cure possible in metastatic gastric cancer?

Chemotherapy in metastatic gastric cancer: opportunities to improve survivalNaureen Starling (UK)

Liver metastases: can we treat like colon cancer? Francisco Castro e Sousa (PT)

Peritoneal disease: is HIPEC still experimental?Guillaume Passot (FR)

Development of strategies to improve quality: the GASTROS StudyBilal Alkhaffaf (UK)

Round Table 3 | Tumors of gastroesophageal junction

New Classification – Clinical implicationsPaula Chaves (PT)

Neo-adjuvant treatment:

Treat like esophagus Florence Huguet (FR)

Treat like gastric Naureen Starling (UK)

Surgical treatment: new perspectives?Paul Schneider (CH)

Directors: César Resende (PT) | Tânia Rodrigues (PT) | Gonçalo Luz (PT) | Rui Maio (PT)

Speakers: Bilal Alkhaffaf | Carla Oliveira | Fátima Carneiro | Florence Huguet | Francisco Castro e Sousa | Guillaume PassotMário Dinis Ribeiro | Naureen Starling | Paula Chaves | Paul Schneider | Pedro Barreiro | Rubens Sallum

Closing remarksMarília Cravo (PT)

06:00 PM

09:00 AM

10:00 AM

08:15 AM

08:45 AM


LEAPING FORWARD ONCOLOGY CARDIO-ONCOLOGY SESSION

Round Table 1 | Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

The American perspective: from the first steps of cardio-oncology to the co-management clinicsJuan Carlos Plana (US)

The European perspective: from the first steps of cardio-oncology to the co-management clinicsRiccardo Asteggiano (IT)

Round Table 2 | Insights into radiotherapy and the heart - past, present and future

Contemporary breast radiotherapy and cardiac toxicity: efforts to reduce riskIsabel Rodriguez (SP)

Challenges in radiotherapy - related heart complicationsJose Juan Gómez de Diego (SP)


Welcome and IntroductionLígia Mendes (PT) | Júlia Toste (PT) | Nuno Cardim (PT)

Discussion

Discussion

Coffee break11:00 AM

11:30 AM

12:30 PM

12:45 PM

Director: Júlia Toste | Lígia Mendes | Nuno Cardim

Speakers: Isabel Rodriguez | Jose Juan Gómez de Diego | Juan Carlos Plana | Luciana Gonçalves | Riccardo AsteggianoTeresa Lopez Fernandez

Round table 3 | Cardio-Oncology: the future is now

Cancer, atrial fibrilation and anticoagulants: the evidence and the futureLuciana Gonçalves (PT)

How new echo techniques can help the cardio-oncology patientTeresa Lopez Fernandez (SP)

COT- European registry of cardio-oncologyNuno Cardim (PT)

Closing remarksJúlia Toste (PT)

Discussion


Welcome and IntroductionLuísa Albuquerque (PT) | Domingos Coiteiro (PT) | Francisco Mascarenhas (PT)

02:00 PM

Surgical treatment of difuse low grade gliomas George Samandouras (UK)

02:15 PM

Round Table | New concepts in the management of low-grade gliomas

Therapeutic approaches with radiation therapy in diffuse low grade gliomas Stephanie E. Combs (DE)

02:55 PM

Difuse low grade gliomas: the vision of the neuro-oncologist Martin van den Bent (NL)

03:35 PM


Advances in surgery George Samandouras (UK)

05:00 PM

Advances in radiation oncologyStephanie E. Combs (DE)

Advances in neuro-oncologyMartin van den Bent (NL)

LEAPING FORWARD ONCOLOGY NEURO ONCOLOGY SESSIONPRELIMINARY PROGRAMME13 MAY 2017 > AUDITORIUM 2

Director: Domingos Coiteiro | Francisco Mascarenhas | Luísa Albuquerque

Speakers: George Samandouras | Martin van den Bent | Stephanie E. Combs

Closing remarksTBD

06:30 PM

08:45 AM

09:00 AM

12:10 PM

09:40 AM

10:20 AM

11:30 AM

11:00 AM

08:15 AM


LEAPING FORWARD ONCOLOGY HEMATOLOGY SESSION

Welcome and IntroductionAntónio Medina Almeida (PT)

Novel molecular technologies for hematological malignanciesCarmo Fonseca (PT)

Closing remarksAntónio Medina Almeida (PT)

Diffuse large B cell lymphomas: new insights in molecular subtyping and next treatment paradigmMaria Gomes da Silva (PT)

Follicular lymphoma: molecular pathogenesis and the role of microenviromentJosé Cabeçadas (PT)

Mutations in myeloid neoplasms: insights into pathophysiology and novel treatment optionsAntónio Medina Almeida (PT)

Coffee Break

Directors: António Medina Almeida

Faculty: Carmo Fonseca | José Cabeçadas | Maria Gomes da Silva


Welcome and IntroductionRaquel Santos (PT) | José Luís Passos Coelho (PT)

02:00 PM

Value of communication, what’s behind the words – train before you need toSara Batalha (PT) | Inês Moura (PT) Human factors approach to manage system variabilityRaquel Santos (PT)

Crisis resource managementDaniela Chaló (PT)


LEAPING FORWARD ONCOLOGY SIMULATION IN ONCOLOGY COMMUNICATION & TEAMWORK SESSION


02:15 PM

03:30 PM

03:00 PM


04:45 PM Demo – Healthcare teams performance in a simulated clinical environmentClinical Team (PT)

Closing remarks TBD

06:00 PM

Director: Raquel Santos | José Luís Passos Coelho

Speakers: Daniela Chaló | Inês Moura | Raquel Santos | Sara Batalha

Documents

LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER …leapingforward.hospitaldaluz.pt/media/277253/programas_total_sem... · in metastatic rectal cancer ... Update on RAPIDO trial - preoperative